Table 2.
Feasibility. Participants transmitted their BP on average 89% of the days under monitoring and 92% of participants transmitted their BP for more than half the monitored days.
Total N = 26 | Days Transmitted | Participants N (%) |
---|---|---|
90 day monitoring N = 19 | 80–90 | 12 (63) |
70–79* | 3 (16) | |
60–69 | 1 (5) | |
50–59 | 1 (5) | |
< 50 | 2 (11) | |
Extended monitoring N=7 | Transmitted daily until HTN controlled or it was felt that control could not be achieved and participant was referred back into primary care | 5 (71) |
Monitored for 103, 107**, 113,115, 121 days | 2 (29) | |
Transmitted 91 of 101 monitored days | ||
Transmitted 173 of 177 days*** |
A total of 3 intervention participants did not meet the primary outcome of BP control as described below.
Had technical difficulties measuring BP.
Was resistant to BP medication addition.
Had fluctuating BP and was referred back to primary care for ambulatory monitoring.